[reaction: see text]. A ruthenium complex, Cp*Ru(bipyridyl)Cl, has been developed as a catalyst for the first regioselective tandem Michael addition-allylic alkylation of activated Michael acceptors. The net transformation is the decarboxylative insertion of Michael acceptors into allyl beta-ketoesters.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: